Related Experiment Video
Updated: Aug 19, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods
Insights
The International Study of Asthma and Allergies in Childhood (ISAAC) investigated global symptom prevalence of asthma and allergies in children. Phase Three aims to map worldwide trends and uncover causes of these common childhood conditions.
Area of Science:
- Pediatric Allergy and Immunology
- Epidemiology
- Global Health
Background:
- The International Study of Asthma and Allergies in Childhood (ISAAC) was established in 1991 to investigate the causes of asthma, allergic rhinoconjunctivitis, and atopic eczema in children globally.
- Phase One revealed significant international variations in symptom prevalence, which current knowledge cannot fully explain.
- Subsequent phases aimed to explore risk and protective factors contributing to these observed differences.
Purpose of the Study:
- To determine the global prevalence of asthma and allergic disease symptoms in children.
- To analyze recent time trends in symptom prevalence worldwide.
- To investigate the underlying causes (aetiology) of asthma and allergic diseases in diverse populations.
Main Methods:
- ISAAC Phase Three replicated Phase One methodology with enhanced standardization across numerous international centers.
- Data collection involved standardized questionnaires administered to children and adolescents.
- The study involved over 280 centers in 106 countries, facilitating large-scale data acquisition.
Main Results:
- Phase One identified substantial global disparities in the prevalence of asthma and allergy symptoms.
- Phase Two focused on identifying environmental and genetic factors influencing these differences.
- Phase Three aimed to provide a comprehensive global map of symptom prevalence and trends.
Conclusions:
- ISAAC Phase Three provides a detailed global overview of asthma and allergy symptom prevalence and trends in children.
- The findings contribute to a better understanding of the aetiology of these conditions worldwide.
- International collaboration and standardized methods are crucial for global epidemiological research.
Abstract:
The International Study of Asthma and Allergies in Childhood (ISAAC) programme commenced in 1991 to study the aetiology of asthma, allergic rhinoconjunctivitis and atopic eczema in children in different populations using standardised methodology and facilitating international collaboration. ISAAC Phase One (1992-1996) found marked differences in the prevalence of symptoms of asthma and allergic disease throughout the world which have not been explained by the current understanding of these diseases. ISAAC Phase Two (1998-2004) uses intensive investigations to further examine the potential role of risk and protective factors that may contribute to the international difference observed in Phase One. Phase Three (2000-2003) essentially represents a repeat of Phase One, in which more detailed standardised data are obtained to enable the time trends of symptom prevalence to be determined as well as the development of a more comprehensive 'world map'. The ISAAC Phase Three rationale and methods are described in this paper. With over 280 centres in 106 countries, we anticipate that ISAAC Phase Three will comprehensively determine the prevalence of symptoms of asthma and allergic disease worldwide, explore recent time trends in the prevalence of these symptoms and cast new light on the aetiology of asthma and allergic disease.
Related Concept Videos
Asthma I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-I: Introduction
